
Biomarin Pharmaceutical Inc (BMRN) is destined for greater heights as its last quarter sales were 745,150 K
Biomarin Pharmaceutical Inc (NASDAQ: BMRN) kicked off on Tuesday, up 0.97% from the previous trading day, before settling in for the closing price of $57.55.